A Phase I Dose Escalation Study Of Heat Activated Liposome Delivery Of Doxorubicin [Thermodox] And Radiofrequency Ablation Of Primary And Metastatic Tumors Of The Liver

Next Previous
Trial Profile

A Phase I Dose Escalation Study Of Heat Activated Liposome Delivery Of Doxorubicin [Thermodox] And Radiofrequency Ablation Of Primary And Metastatic Tumors Of The Liver

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Mar 2016

At a glance

  • Drugs Doxorubicin liposomal (Primary)
  • Indications Cancer metastases; Liver cancer
  • Focus Adverse reactions; Pharmacokinetics

    • Most Recent Events

    • 14 Mar 2012 Actual end date changed from Feb 2010 to Jan 2011 as reported by ClinicalTrials.gov.
    • 14 Mar 2012 Actual end date changed from Feb 2010 to Jan 2011 as reported by ClinicalTrials.gov.
    • 14 Mar 2012 Actual end date changed from Feb 2010 to Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top